Search

Solution structure of LEDGF/p75 IBD in complex with MLL1 peptide (140-160)
Authors
Cermakova, K., Tesina, P., Demeulemeester, J., El Ashkar, S., Mereau, H., Schwaller, J., Rezacova, P., Veverka, V., De Rijck, J.
Assembly
LEDGF/p75 IBD in complex with MLL1 peptide (140-160)
Entity
1. MLL1 140-160 (polymer, Thiol state: not present), 21 monomers, 2270.327 Da Detail

GGSGEDEQFL GFGSDEEVRV R


2. IBD (polymer, Thiol state: all free), 88 monomers, 10242.81 Da Detail

SNAASRETSM DSRLQRIHAE IKNSLKIDNL DVNRCIEALD ELASLQVTMQ QAQKHTEMIT TLKKIRRFKV SQVIMEKSTM LYNKFKNM


Total weight
12513.137 Da
Max. entity weight
10242.81 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
torsion angle dynamics, molecular dynamics
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 97.2 %, Completeness: 83.6 %, Completeness (bb): 83.8 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All83.6 % (1077 of 1289)90.0 % (611 of 679)76.8 % (375 of 488)74.6 % (91 of 122)
Backbone83.8 % (548 of 654)91.5 % (204 of 223)80.4 % (259 of 322)78.0 % (85 of 109)
Sidechain83.5 % (617 of 739)89.3 % (407 of 456)75.6 % (204 of 270)46.2 % (6 of 13)
Aromatic44.6 % (25 of 56)85.7 % (24 of 28) 3.6 % (1 of 28)
Methyl93.8 % (105 of 112)98.2 % (55 of 56)89.3 % (50 of 56)

1. MLL1 140-160

GGSGEDEQFL GFGSDEEVRV R

2. IBD

SNAASRETSM DSRLQRIHAE IKNSLKIDNL DVNRCIEALD ELASLQVTMQ QAQKHTEMIT TLKKIRRFKV SQVIMEKSTM LYNKFKNM

Sample

Solvent system 95% H2O/5% D2O, Pressure 1 atm, Temperature 298 K, pH 7


#NameIsotope labelingTypeConcentration
1MLL1_140-160natural abundance0.5 mM
2IBD[U-13C; U-15N]0.5 mM
3HEPESnatural abundance25 mM
4sodium chloridenatural abundance100 mM
5beta-mercaptoethanolnatural abundance0.05 %

LACS Plot; CA
Referencing offset: -0.02 ppm, Outliers: 4 Detail
LACS Plot; CB
Referencing offset: -0.02 ppm, Outliers: 4 Detail
LACS Plot; HA
Referencing offset: 0.06 ppm, Outliers: 2 Detail
LACS Plot; CO
Referencing offset: 0.06 ppm, Outliers: 1 Detail
Protein Blocks Logo
Calculated from 20 models in PDB: 2MSR, Strand ID: A, B Detail


Release date
2014-08-24
Citation
Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia
Cermakova, K., Tesina, P., Demeulemeester, J., El Ashkar, S., Mereau, H., Schwaller, J., Rezacova, P., Veverka, V., De Rijck, J.
Cancer. Res. (2014), 74, 5139-5151, PubMed 25082813 , DOI 10.1158/0008-5472.CAN-13-3602 ,
Related entities 1. MLL1 140-160, : 1 : 3 entities Detail
Related entities 2. IBD, : 7 : 17 entities Detail
Interaction partners 1. MLL1 140-160, : 37 : 1 interactors Detail
Interaction partners 2. IBD, : 13 interactors Detail
Experiments performed 9 experiments Detail
nullKeywords LEDGF/p75, MLL, Mixed Lineage Leukemia, NMR